MicroRNA-93 Controls Perfusion Recovery After Hindlimb Ischemia by Modulating Expression of Multiple Genes in the Cell Cycle Pathway

• Published in: Circulation (New York, N.Y.) N.Y.), 2013-04, Vol.127 (17), p.1818-1828
• Main Authors: HAZARIKA, Surovi, FARBER, Charles R, DOKUN, Ayotunde O, PITSILLIDES, Achillieas N, TAO WANG, LYE, R. John, ANNEX, Brian H
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cell Cycle - genetics; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Gene Expression Regulation; Gene Knockdown Techniques; Hindlimb - blood supply; Hindlimb - metabolism; Human Umbilical Vein Endothelial Cells - metabolism; Humans; Ischemia - genetics; Ischemia - metabolism; Ischemia - physiopathology; Male; Medical sciences; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; MicroRNAs - physiology; Recovery of Function - physiology; Reperfusion - methods
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/circulationaha.112.000860

MicroRNAs are key regulators of gene expression in response to injury, but there is limited knowledge of their role in ischemia-induced angiogenesis, such as in peripheral arterial disease. Here, we used an unbiased strategy and took advantage of different phenotypic outcomes that follow surgically induced hindlimb ischemia between inbred mouse strains to identify key microRNAs involved in perfusion recovery from hindlimb ischemia. From comparative microRNA profiling between inbred mouse strains that display profound differences in their extent of perfusion recovery after hindlimb ischemia, we found that the mouse strain with higher levels of microRNA-93 (miR-93) in hindlimb muscle before ischemia and the greater ability to upregulate miR-93 in response to ischemia had better perfusion recovery. In vitro, overexpression of miR-93 attenuated hypoxia-induced apoptosis in both endothelial and skeletal muscle cells and enhanced proliferation in both cell types. In addition, miR-93 overexpression enhanced endothelial cell tube formation. In vivo, miR-93 overexpression enhanced capillary density and perfusion recovery from hindlimb ischemia, and antagomirs to miR-93 attenuated perfusion recovery. Both in vitro and in vivo modulation of miR-93 resulted in alterations in the expression of >1 cell cycle pathway gene in 2 different cell types. Our data indicate that miR-93 enhances perfusion recovery from hindlimb ischemia by modulation of multiple genes that coordinate the functional pathways of cell proliferation and apoptosis. Thus, miR-93 is a strong potential target for pharmacological modulation to promote angiogenesis in ischemic tissue.